New developments in postmenopausal hormone replacement therapy

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 3, 1997, Pages 207-212

  Prelevic, Gordana M ^a   Jacobs, Howard S ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY RISK; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 0030755411     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199706000-00013     Document Type: Review

References (47)

1. Prevelic G, Jacobs HS: Menopause and postmenopause. In Bailliere's Clinical Endocrinology and Metabolism. Endocrinology of Ageing. London: Bailliere Tindall; 1997, in press.
2. Jacobs HS, Loeffler FE: Regular review: postmenopausal hormone replacement therapy. BMJ 1992, 305:1403-1408.
3. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM: Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Int Med 1990, 150:2557-2562.
4. Sullivan JM, El Zeky F, Vander Zwaag R, Ramanathan KB: Oestrogen replacement therapy after coronary artery bypass surgery: effect on survival. J Am Coll Cardiol 1994, 23:49A.
5. Crook D: Postmenopausal hormone replacement therapy, lipopro•• tein metabolism and coronary heart disease. J Cardiovasc Pharmacol 1996, 28(Suppl 5):S40-S45. This is an excellent review of the effects of various forms of HRT on serum lipoprotein profile and the risk for cardiovascular disease.
6. Tonstad S, Ose L, Gorbitz C, Djoseland O, Bard JM, Pruchard JC: Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Int Med 1995, 238:39-47.
7. Brinton EA: Oral oestrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-l and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996, 16, 431-440.
8. Crook D, Stevenson JC: Trandermal hormone replacement therapy, • serum lipids and lipoporteins. Br J Clin Pract 1996, (Suppl 86):17-21. An excellent summary of the effects of transdermal oestradiol on serum lipoprotein changes in postmenopausal women and potential implications for a decrease in the risk for cardiovascular disease.
9. Rymer J, Crook D, Sidhan M, Chapman M, Stevenson JC: Effects of tibolone on serum concentrations of lipoprotein 9(a) in postmenopausal women. Acta Endocrinol 1993, 128:259-262.
10. The writing group for the PEPI trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) trial. J Am Med Assoc 1995, 273:199-208.
11. Crook D, Godsland IF, Stevenson JC: The cardiovascular risk profile of hormone replacement therapies containing dydrigesterone: a review. Eur Menopause J 1995, 2(suppl 4):25-30.
12. Sack NM, Rader DJ, O'Cannon R: Oestrogen and inhibition of oxidation of low-density lipoproteins in post-menopausal women. Lancet 1994, 343:269-270.
13. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z: Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993, 77:1095-1097.
14. Nabulsi AA, Folsom AR, Szklo M, White A, Higgins M, Heiss G: No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation 1996, 94:1957-1963.
15. Sullivan JM: Hormone replacement therapy and cardiovascular disease: the human model. Br J Obstet Gynaecol 1996, 103(Suppl 13):59-67.
16. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO: Acute vascular effects of oestrogen in postmenopausal women. Circulation 1994, 90:786-791.
17. Williams JK, Adams MR, Clarkson TB: Effect of oestrogens on vascular tone. J Cardiovasc Pharmacol 1996, 28(suppl 5): S29-S33.
18. Collins P, Rosano GMC, Sarrel PM, Ulrich I, Adamopoulos S, Reale CM, McNeill JG, Poole-Wilson PA: 17beta oestradiol attenuates acetylcholine-induced coronary arteria; constriction in women but not men with coronary heart disease. Circulation 1995, 92:24-30.
19. Weiner CP, Llzasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium dependent nitric oxide synthases by sex hormones. Proc Nat Acad Sci USA 1994, 91:5212-5216.
20. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK: Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17-beta oestradiol and norethisteron acetate: a two year follow-up study. Hypertension 1995, 25:848-853.
21. Ylikorkala O, Orpana A, Puolakka J, Pyorala T, Viinikka I Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 1995, 80:3384-3387.
22. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P: Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993, 342:133-136.
23. Sarrel PM: How progestins compromise the cardioprotective effects of estrogens. Menopause 1995, 2:187-190.
24. Williams JK, Honore EK, Wasburn SA, Clarkson TB: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994, 24:1757-1761.
25. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763.
26. Yang Z, Do DD, Espinosa E, Barton M, Arnet U, Luscher TP: 17-beta-oestradiol inhibits growth of human vascular smooth muscle: similar effects in cells from females and males. J Cardiovasc Pharmacol 1996, 28(suppl 5):S34-S39.
27. Chen SJ, Li H, Durand J, Oparal S, Chen YF: Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996, 93:577-584.
28. Akkad A, Hartshorne T, Bell PR, Al-Azzawi F: Carotid plaque regression on oestrogen replacement: a pilot study. Eur J Vasc Endovasc Surg 1996, 11:347-348.
29. Prelevic GM, Beljic T: The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 1994, 20:37-44.
30. Proudler AJ, Ahmed AIH, Crook D, Fogelman I, Rymer JM, Stevenson JC: Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women. Lancet 1995, 346:89-90.
31. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk TZ, Lobo RA: A possible bimodal effect of oestrogen on insulin sensitivity in postmenopausal women and attenuating effect of added progestin. Fertil Steril 1993, 60:664-667.
32. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG: Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994, 51:896-900.
33. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140:256-261.
34. Paganini-Hill A: Oestrogen replacement therapy and Alzheimer's disease. Br J Obstet Gynaecol 1996, 103(suppl 13):80-86.
35. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland R, •• Andrews H, Maycux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348:429-432. This is an important study which provides evidence that oestrogen use in postmenopausal women may delay the onset and decrease the risk of Alzheimer's disease.
36. Honjo H, Tonekie K, Koshiwzi T, Urabe M, Okada H, Hayashi M, Hayashi K: Senile dementia - Alzheimer's type and estrogen. Horm Metab Res 1995, 27:204-207.
37. Ohkura T, Isse K, Akazawa K, Hamanoto M, Yaoi Y, Hagino N: Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1994, 1:125-131.
38. Luine VN: Oestradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas in female rats. Exp Neurol 1985, 89:484-490.
39. Phillip S, Shervin B: Effects of estrogen on neuronal function in postmenopausal women. Psychoneuroendocrinology 1992, 17:485-498.
40. Wong M, Moss RL: Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 1992, 12:3217-3225.
41. Gould E, Woodley C, Frankfurt M, McEwen B: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990, 10:1286-1291.
42. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Nat Cancer Inst 1995, 87:517-523.
43. Newcomb PA, Storer E: Postmenopausal hormone use and risk of large-bowel cancer. J Nat Cancer Inst 1995, 87:1067-1071.
44. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N: Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Nat Cancer Inst 1995, 87:645-651.
45. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994, 7:536-540.
46. Lontier P, Wildrick DM, Boman BM: The effects of steroid hormones on a human, colon cancer cell line in vitro. Anticancer Res 1992, 12:1327-1330.
47. McMichael AJ, Potter JD: Do intrinsic sex differences in lower alimentary tract physiology influence the sex specific risks of bowel cancer and other biliary and intestinal disease? Am J Epidemiol 1983, 118:620-627.